June 18 2026

New Mesothelioma Guidelines

We are excited and proud to announce that the new consensus-based GUIDELINES AND RECOMMENDATIONS FOR THE MANAGEMENT OF PLEURAL MESOTHELIOMA IN AUSTRALIA is now available.

The last guidelines were published by ADRI (as we were back then) in 2013, and much has changed in the evidence base and care landscape over the past 13 years.  These latest clinical practice guidelines will now provide an essential reference for Australian medical practitioners, nurses and other allied health professionals and aims to ensure that all people affected by mesothelioma receive the highest standard of care, regardless of where they live in the community.

ADDRI assembled a national committee of Australia’s leading mesothelioma experts, led by Chair Professor Sonja Klebe and ADDRI Academic and Research Director A/Prof Anthony Linton, spanning the fields of epidemiology, radiology, pathology, palliative care, medical oncology, medicolegal, survivorship and consumers.  Everyone came together with the shared purpose to provide patients and colleagues with guidance and support when it is most needed.  We thank all contributors for their expertise, guidance and commitment over the two-year development process.  In particular, we wish to acknowledge and thank our members with lived experience, who ensured that we never lost sight of that shared goal.

The guidelines cover topics from initial symptom presentation all the way through to end-of life considerations including diagnosis staging, treatment options, compensation, genetic counselling for family members and palliative care. Even with a world class health system like Australia, misdiagnosis of mesothelioma cases continues to be a problem. Given the need to reduce misdiagnoses, the importance of these new guidelines is clear.

Thank you to icare NSW and the Australian Government Asbestos and Silica Safety and Eradication Agency for their funding and support of this significant project.

You can read the guidelines here.

 

 

Read more

ADDRI acknowledges and thanks the Committee Members for their expertise and their commitment to bring this vital project to life.

SPECIALITY AREA MEMBER
Epidemiology Prof Tim Driscoll, NSW
Prof David Roder, SA
General Practice Prof Andrew Bonney, NSW
Radiology Prof Catherine Jones, QLD
Dr Michael Jones, NSW
Physician Prof Gary Lee, WA
Dr Anthony Johnson, NSW
Pathology Prof Sonja Klebe, SA
Prof Wendy Cooper, NSW
Treatment/Surgery Dr Jazmin Eckhaus, VIC
Dr Stephen A Barnett, VIC
Palliative care Prof David Currow, NSW
Dr Vanessa Brunelli, NSW
Medical oncology Prof Nick Pavlakis, NSW
Prof Stephen Clarke, NSW
Prof Kenneth O’Byrne, QLD
Dr Melvin Chin, WA
Prof Tom John, VIC
A/Prof Steven Kao, NSW
A/Prof Anthony Linton
Radiation oncology Prof Nicholas Bucknell, WA
Dr Mo Mo Tin, NSW
Genetics Prof Tom John, VIC
Prof Paul James, VIC
Supportive care/ Nursing Dr Vanessa Brunelli, NSW
Jocelyn McLean, NSW
Survivorship Dr Ashanya Malalasekera, NSW
Medico-legal Prof Phillip Parente, VIC
Consumer Vicki Hamilton, VIC
Jennifer Weismantel, NSW

Sign up to our newsletter

Sign up
Skip to content